Indoleamine-2,3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapy

By                      

International Journal of Oncology, Vol. 40, Iss. 4, 2012-01 ,pp. : 929-934

Spandidos Publications

Access to resources Recommend Favorite

Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT

By Ou Xueling   Cai Shaohui   Liu Peng   Zeng Jun   He Yuwen   Wu Xinyao   Du Jun  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 5, 2008-05 ,pp. : 525-533

Springer Publishing Company

Access to resources Recommend Favorite

Downregulation of vasohibin-2, a novel angiogenesis regulator, suppresses tumor growth by inhibiting angiogenesis in endometrial cancer cells

By            

Oncology Letters, Vol. 5, Iss. 3, 2013-01 ,pp. : 1058-1062

Spandidos Publications

Access to resources Recommend Favorite

Downregulation of NOB1 suppresses the proliferation and tumor growth of non-small cell lung cancer in vitro and in vivo

By            

Oncology Reports, Vol. 31, Iss. 3, 2014-01 ,pp. : 1271-1276

Spandidos Publications

Access to resources Recommend Favorite

(-)-Epigallocatechin gallate inhibits the expression of indoleamine 2,3-dioxygenase in human colorectal cancer cells

By                      

Oncology Letters, Vol. 4, Iss. 3, 2012-01 ,pp. : 546-550

Spandidos Publications

Access to resources Recommend Favorite